nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—HTR2A—choroid plexus—malignant glioma	0.0877	0.122	CbGeAlD
Acepromazine—DRD1—telencephalic ventricle—malignant glioma	0.0659	0.092	CbGeAlD
Acepromazine—HTR2A—cerebellar cortex—malignant glioma	0.0442	0.0617	CbGeAlD
Acepromazine—HTR1A—telencephalic ventricle—malignant glioma	0.0431	0.0602	CbGeAlD
Acepromazine—DRD2—telencephalic ventricle—malignant glioma	0.0389	0.0544	CbGeAlD
Acepromazine—HTR2A—pons—malignant glioma	0.0312	0.0436	CbGeAlD
Acepromazine—HTR2A—vertebral column—malignant glioma	0.031	0.0433	CbGeAlD
Acepromazine—HTR2A—telencephalic ventricle—malignant glioma	0.0257	0.0359	CbGeAlD
Acepromazine—HTR2A—pineal body—malignant glioma	0.0223	0.0311	CbGeAlD
Acepromazine—DRD1—brainstem—malignant glioma	0.0178	0.0249	CbGeAlD
Acepromazine—DRD1—telencephalon—malignant glioma	0.0158	0.0221	CbGeAlD
Acepromazine—HTR2A—endothelium—malignant glioma	0.0138	0.0192	CbGeAlD
Acepromazine—HTR2A—blood vessel—malignant glioma	0.0127	0.0178	CbGeAlD
Acepromazine—Trifluoperazine—CALY—malignant glioma	0.0127	0.282	CrCbGaD
Acepromazine—SLC22A1—telencephalon—malignant glioma	0.0125	0.0175	CbGeAlD
Acepromazine—HTR1A—brainstem—malignant glioma	0.0117	0.0163	CbGeAlD
Acepromazine—DRD1—midbrain—malignant glioma	0.0114	0.0159	CbGeAlD
Acepromazine—ADRA1A—brainstem—malignant glioma	0.0108	0.015	CbGeAlD
Acepromazine—DRD2—brainstem—malignant glioma	0.0105	0.0147	CbGeAlD
Acepromazine—HTR1A—telencephalon—malignant glioma	0.0104	0.0144	CbGeAlD
Acepromazine—DRD2—retina—malignant glioma	0.0102	0.0142	CbGeAlD
Acepromazine—ADRA1B—central nervous system—malignant glioma	0.00965	0.0135	CbGeAlD
Acepromazine—ADRA1A—telencephalon—malignant glioma	0.00954	0.0133	CbGeAlD
Acepromazine—DRD2—telencephalon—malignant glioma	0.00935	0.0131	CbGeAlD
Acepromazine—DRD1—central nervous system—malignant glioma	0.009	0.0126	CbGeAlD
Acepromazine—ADRA1B—brain—malignant glioma	0.00766	0.0107	CbGeAlD
Acepromazine—HTR2A—embryo—malignant glioma	0.00759	0.0106	CbGeAlD
Acepromazine—HTR1A—midbrain—malignant glioma	0.00743	0.0104	CbGeAlD
Acepromazine—HTR1A—spinal cord—malignant glioma	0.00725	0.0101	CbGeAlD
Acepromazine—DRD1—brain—malignant glioma	0.00714	0.00997	CbGeAlD
Acepromazine—SLC22A1—central nervous system—malignant glioma	0.00712	0.00994	CbGeAlD
Acepromazine—HTR2A—brainstem—malignant glioma	0.00695	0.0097	CbGeAlD
Acepromazine—DRD2—midbrain—malignant glioma	0.00672	0.00938	CbGeAlD
Acepromazine—HTR2A—retina—malignant glioma	0.00671	0.00936	CbGeAlD
Acepromazine—HTR2A—telencephalon—malignant glioma	0.00617	0.00861	CbGeAlD
Acepromazine—HTR1A—central nervous system—malignant glioma	0.00588	0.00821	CbGeAlD
Acepromazine—HTR1A—cerebellum—malignant glioma	0.00575	0.00803	CbGeAlD
Acepromazine—SLC22A1—brain—malignant glioma	0.00566	0.00789	CbGeAlD
Acepromazine—ADRA1A—central nervous system—malignant glioma	0.00542	0.00757	CbGeAlD
Acepromazine—ALB—brain—malignant glioma	0.00541	0.00756	CbGeAlD
Acepromazine—DRD2—central nervous system—malignant glioma	0.00532	0.00742	CbGeAlD
Acepromazine—ADRA1A—cerebellum—malignant glioma	0.0053	0.0074	CbGeAlD
Acepromazine—DRD2—cerebellum—malignant glioma	0.0052	0.00725	CbGeAlD
Acepromazine—HTR2A—medulla oblongata—malignant glioma	0.00485	0.00677	CbGeAlD
Acepromazine—HTR1A—brain—malignant glioma	0.00467	0.00652	CbGeAlD
Acepromazine—HTR2A—midbrain—malignant glioma	0.00443	0.00618	CbGeAlD
Acepromazine—HTR2A—spinal cord—malignant glioma	0.00432	0.00603	CbGeAlD
Acepromazine—ADRA1A—brain—malignant glioma	0.00431	0.00601	CbGeAlD
Acepromazine—DRD2—brain—malignant glioma	0.00422	0.00589	CbGeAlD
Acepromazine—Ethopropazine—BCHE—malignant glioma	0.00358	0.0796	CrCbGaD
Acepromazine—HTR2A—central nervous system—malignant glioma	0.00351	0.00489	CbGeAlD
Acepromazine—HTR2A—cerebellum—malignant glioma	0.00343	0.00478	CbGeAlD
Acepromazine—Clomipramine—GSTP1—malignant glioma	0.00301	0.0668	CrCbGaD
Acepromazine—Perphenazine—CYP2C18—malignant glioma	0.00294	0.0655	CrCbGaD
Acepromazine—Triflupromazine—BCHE—malignant glioma	0.00293	0.0652	CrCbGaD
Acepromazine—HTR2A—brain—malignant glioma	0.00278	0.00389	CbGeAlD
Acepromazine—Desipramine—CYP2C18—malignant glioma	0.00274	0.0609	CrCbGaD
Acepromazine—Imipramine—CYP2C18—malignant glioma	0.00232	0.0517	CrCbGaD
Acepromazine—Promethazine—CYP2B6—malignant glioma	0.00224	0.0498	CrCbGaD
Acepromazine—Perphenazine—CYP2B6—malignant glioma	0.00219	0.0486	CrCbGaD
Acepromazine—Desipramine—CYP2B6—malignant glioma	0.00203	0.0452	CrCbGaD
Acepromazine—Trimipramine—SLC6A3—malignant glioma	0.00198	0.0441	CrCbGaD
Acepromazine—Desipramine—SLC6A3—malignant glioma	0.00173	0.0385	CrCbGaD
Acepromazine—Imipramine—CYP2B6—malignant glioma	0.00172	0.0383	CrCbGaD
Acepromazine—Imipramine—SLC6A3—malignant glioma	0.00147	0.0327	CrCbGaD
Acepromazine—Chlorpromazine—BCHE—malignant glioma	0.00142	0.0315	CrCbGaD
Acepromazine—ALB—Metabolism—CAT—malignant glioma	5.94e-05	0.000249	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	5.92e-05	0.000248	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL2—malignant glioma	5.87e-05	0.000246	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CAV1—malignant glioma	5.87e-05	0.000246	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—F2—malignant glioma	5.87e-05	0.000246	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—FN1—malignant glioma	5.87e-05	0.000246	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TERT—malignant glioma	5.85e-05	0.000245	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—KDR—malignant glioma	5.81e-05	0.000243	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—BAD—malignant glioma	5.8e-05	0.000243	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL2—malignant glioma	5.78e-05	0.000242	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TERT—malignant glioma	5.76e-05	0.000241	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NOTCH1—malignant glioma	5.74e-05	0.000241	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PIK3CD—malignant glioma	5.74e-05	0.000241	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PDGFB—malignant glioma	5.71e-05	0.000239	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—PIK3CA—malignant glioma	5.69e-05	0.000238	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—FGFR1—malignant glioma	5.68e-05	0.000238	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL2—malignant glioma	5.66e-05	0.000237	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TERT—malignant glioma	5.64e-05	0.000236	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CD80—malignant glioma	5.63e-05	0.000236	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—KRAS—malignant glioma	5.62e-05	0.000235	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PDGFB—malignant glioma	5.62e-05	0.000235	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PIK3CG—malignant glioma	5.62e-05	0.000235	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—APC—malignant glioma	5.62e-05	0.000235	CbGpPWpGaD
Acepromazine—ALB—Metabolism—NCOR1—malignant glioma	5.61e-05	0.000235	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HIF1A—malignant glioma	5.6e-05	0.000234	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—FGFR1—malignant glioma	5.59e-05	0.000234	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—F2—malignant glioma	5.59e-05	0.000234	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—FN1—malignant glioma	5.59e-05	0.000234	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—EGF—malignant glioma	5.55e-05	0.000233	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—BAD—malignant glioma	5.52e-05	0.000231	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PTPN11—malignant glioma	5.52e-05	0.000231	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—HIF1A—malignant glioma	5.51e-05	0.000231	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	5.5e-05	0.000231	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—FGF2—malignant glioma	5.5e-05	0.00023	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	5.47e-05	0.000229	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PIK3CD—malignant glioma	5.47e-05	0.000229	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NOTCH1—malignant glioma	5.47e-05	0.000229	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CAV1—malignant glioma	5.41e-05	0.000227	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	5.39e-05	0.000226	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CD80—malignant glioma	5.36e-05	0.000224	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—KDR—malignant glioma	5.35e-05	0.000224	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PIK3CG—malignant glioma	5.35e-05	0.000224	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—APC—malignant glioma	5.35e-05	0.000224	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CAV1—malignant glioma	5.33e-05	0.000223	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—EGF—malignant glioma	5.29e-05	0.000221	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—BRAF—malignant glioma	5.28e-05	0.000221	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—KDR—malignant glioma	5.27e-05	0.000221	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PTPN11—malignant glioma	5.25e-05	0.00022	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—KRAS—malignant glioma	5.22e-05	0.000219	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CAV1—malignant glioma	5.22e-05	0.000218	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—PIK3CA—malignant glioma	5.16e-05	0.000216	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—KDR—malignant glioma	5.16e-05	0.000216	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—F2—malignant glioma	5.15e-05	0.000216	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—FN1—malignant glioma	5.15e-05	0.000216	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MDM2—malignant glioma	5.14e-05	0.000215	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AKT2—malignant glioma	5.14e-05	0.000215	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—RAF1—malignant glioma	5.13e-05	0.000215	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—EGFR—malignant glioma	5.12e-05	0.000214	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—BAD—malignant glioma	5.09e-05	0.000213	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ERBB2—malignant glioma	5.07e-05	0.000212	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—F2—malignant glioma	5.07e-05	0.000212	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—FN1—malignant glioma	5.07e-05	0.000212	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NOTCH1—malignant glioma	5.04e-05	0.000211	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—BRAF—malignant glioma	5.03e-05	0.000211	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—BAD—malignant glioma	5.01e-05	0.00021	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PIK3CB—malignant glioma	5e-05	0.00021	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—FN1—malignant glioma	4.96e-05	0.000208	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—F2—malignant glioma	4.96e-05	0.000208	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NOTCH1—malignant glioma	4.96e-05	0.000208	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CD80—malignant glioma	4.94e-05	0.000207	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	4.94e-05	0.000207	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PIK3CG—malignant glioma	4.93e-05	0.000207	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—APC—malignant glioma	4.93e-05	0.000207	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—BAD—malignant glioma	4.9e-05	0.000205	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AKT2—malignant glioma	4.89e-05	0.000205	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	4.89e-05	0.000205	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—EGF—malignant glioma	4.87e-05	0.000204	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—EGFR—malignant glioma	4.87e-05	0.000204	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CD80—malignant glioma	4.86e-05	0.000204	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	4.86e-05	0.000204	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PIK3CG—malignant glioma	4.85e-05	0.000203	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—APC—malignant glioma	4.85e-05	0.000203	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PTPN11—malignant glioma	4.84e-05	0.000203	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—KRAS—malignant glioma	4.83e-05	0.000202	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CXCL8—malignant glioma	4.81e-05	0.000201	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—PIK3CA—malignant glioma	4.8e-05	0.000201	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—EGF—malignant glioma	4.8e-05	0.000201	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PIK3CB—malignant glioma	4.77e-05	0.0002	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PTPN11—malignant glioma	4.77e-05	0.0002	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CD80—malignant glioma	4.76e-05	0.000199	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—APC—malignant glioma	4.75e-05	0.000199	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	4.75e-05	0.000199	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PTGS2—malignant glioma	4.73e-05	0.000198	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—FGF2—malignant glioma	4.73e-05	0.000198	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PIK3CD—malignant glioma	4.7e-05	0.000197	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—EGF—malignant glioma	4.7e-05	0.000197	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	4.67e-05	0.000196	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—PIK3CA—malignant glioma	4.66e-05	0.000195	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—AKT1—malignant glioma	4.65e-05	0.000195	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—TP53—malignant glioma	4.64e-05	0.000195	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—BRAF—malignant glioma	4.63e-05	0.000194	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—KRAS—malignant glioma	4.6e-05	0.000193	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CASP3—malignant glioma	4.6e-05	0.000193	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL2—malignant glioma	4.6e-05	0.000193	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CAV1—malignant glioma	4.57e-05	0.000192	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—BRAF—malignant glioma	4.56e-05	0.000191	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AKT2—malignant glioma	4.51e-05	0.000189	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—FGF2—malignant glioma	4.5e-05	0.000189	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—EGFR—malignant glioma	4.49e-05	0.000188	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—BRAF—malignant glioma	4.47e-05	0.000187	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	4.44e-05	0.000186	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AKT2—malignant glioma	4.44e-05	0.000186	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MDM2—malignant glioma	4.42e-05	0.000185	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—EGFR—malignant glioma	4.42e-05	0.000185	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—RAF1—malignant glioma	4.41e-05	0.000185	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.37e-05	0.000183	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ERBB2—malignant glioma	4.36e-05	0.000183	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MMP9—malignant glioma	4.35e-05	0.000182	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AKT2—malignant glioma	4.35e-05	0.000182	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	4.33e-05	0.000182	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	4.33e-05	0.000181	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PTEN—malignant glioma	4.32e-05	0.000181	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	4.3e-05	0.00018	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	4.29e-05	0.00018	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	4.26e-05	0.000179	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—KRAS—malignant glioma	4.24e-05	0.000178	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	4.23e-05	0.000177	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	4.22e-05	0.000177	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—AKT1—malignant glioma	4.22e-05	0.000177	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MDM2—malignant glioma	4.21e-05	0.000176	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—RAF1—malignant glioma	4.2e-05	0.000176	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	4.18e-05	0.000175	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—KRAS—malignant glioma	4.18e-05	0.000175	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PIK3CG—malignant glioma	4.17e-05	0.000175	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	4.15e-05	0.000174	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—FGF2—malignant glioma	4.15e-05	0.000174	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	4.14e-05	0.000173	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CXCL8—malignant glioma	4.14e-05	0.000173	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PTEN—malignant glioma	4.12e-05	0.000173	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	4.1e-05	0.000172	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	4.09e-05	0.000171	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—FGF2—malignant glioma	4.08e-05	0.000171	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PPARG—malignant glioma	4.02e-05	0.000168	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—FGF2—malignant glioma	4e-05	0.000168	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	3.99e-05	0.000167	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CASP3—malignant glioma	3.96e-05	0.000166	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL2—malignant glioma	3.95e-05	0.000166	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	3.94e-05	0.000165	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—AKT1—malignant glioma	3.92e-05	0.000164	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—VEGFA—malignant glioma	3.91e-05	0.000164	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	3.9e-05	0.000163	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MDM2—malignant glioma	3.88e-05	0.000163	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—RAF1—malignant glioma	3.87e-05	0.000162	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—STAT3—malignant glioma	3.87e-05	0.000162	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	3.84e-05	0.000161	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ERBB2—malignant glioma	3.83e-05	0.00016	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MDM2—malignant glioma	3.82e-05	0.00016	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—RAF1—malignant glioma	3.81e-05	0.00016	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	3.8e-05	0.000159	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	3.78e-05	0.000158	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	3.77e-05	0.000158	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	3.77e-05	0.000158	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL2—malignant glioma	3.76e-05	0.000158	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	3.76e-05	0.000157	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	3.74e-05	0.000157	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MMP9—malignant glioma	3.74e-05	0.000157	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	3.73e-05	0.000156	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PTEN—malignant glioma	3.72e-05	0.000156	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	3.72e-05	0.000156	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	3.69e-05	0.000155	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PIK3CD—malignant glioma	3.66e-05	0.000153	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	3.64e-05	0.000153	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CXCL8—malignant glioma	3.63e-05	0.000152	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	3.63e-05	0.000152	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MYC—malignant glioma	3.59e-05	0.000151	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	3.57e-05	0.00015	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	3.56e-05	0.000149	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	3.54e-05	0.000148	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—EGFR—malignant glioma	3.51e-05	0.000147	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	3.51e-05	0.000147	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	3.5e-05	0.000147	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CASP3—malignant glioma	3.47e-05	0.000146	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL2—malignant glioma	3.47e-05	0.000145	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	3.45e-05	0.000145	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	3.45e-05	0.000145	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CASP3—malignant glioma	3.42e-05	0.000143	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL2—malignant glioma	3.41e-05	0.000143	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	3.38e-05	0.000142	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	3.36e-05	0.000141	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	3.35e-05	0.00014	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL2—malignant glioma	3.34e-05	0.00014	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—STAT3—malignant glioma	3.33e-05	0.000139	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—KRAS—malignant glioma	3.32e-05	0.000139	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MMP9—malignant glioma	3.28e-05	0.000138	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PTEN—malignant glioma	3.26e-05	0.000137	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MMP9—malignant glioma	3.23e-05	0.000135	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PTEN—malignant glioma	3.21e-05	0.000135	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	3.2e-05	0.000134	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PIK3CB—malignant glioma	3.19e-05	0.000134	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—AKT1—malignant glioma	3.18e-05	0.000133	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	3.17e-05	0.000133	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	3.16e-05	0.000133	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PTGS2—malignant glioma	3.16e-05	0.000133	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	3.15e-05	0.000132	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	3.13e-05	0.000131	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MYC—malignant glioma	3.09e-05	0.000129	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	3.07e-05	0.000129	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	3.05e-05	0.000128	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—EGFR—malignant glioma	3.02e-05	0.000127	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TP53—malignant glioma	2.95e-05	0.000124	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—VEGFA—malignant glioma	2.95e-05	0.000124	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MYC—malignant glioma	2.94e-05	0.000123	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—STAT3—malignant glioma	2.92e-05	0.000122	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PIK3CA—malignant glioma	2.91e-05	0.000122	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	2.9e-05	0.000122	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	2.88e-05	0.000121	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—STAT3—malignant glioma	2.87e-05	0.00012	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—KRAS—malignant glioma	2.86e-05	0.00012	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	2.84e-05	0.000119	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	2.81e-05	0.000118	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PTEN—malignant glioma	2.76e-05	0.000116	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	2.72e-05	0.000114	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MYC—malignant glioma	2.71e-05	0.000114	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MYC—malignant glioma	2.67e-05	0.000112	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—EGFR—malignant glioma	2.65e-05	0.000111	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	2.62e-05	0.00011	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MYC—malignant glioma	2.61e-05	0.00011	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—EGFR—malignant glioma	2.61e-05	0.000109	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	2.56e-05	0.000107	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TP53—malignant glioma	2.54e-05	0.000106	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—KRAS—malignant glioma	2.51e-05	0.000105	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	2.5e-05	0.000105	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—AKT1—malignant glioma	2.49e-05	0.000104	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—KRAS—malignant glioma	2.47e-05	0.000103	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TP53—malignant glioma	2.42e-05	0.000101	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	2.42e-05	0.000101	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—AKT1—malignant glioma	2.38e-05	9.96e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	2.3e-05	9.65e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	2.27e-05	9.49e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TP53—malignant glioma	2.23e-05	9.33e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	2.22e-05	9.3e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TP53—malignant glioma	2.19e-05	9.18e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TP53—malignant glioma	2.15e-05	8.99e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AKT1—malignant glioma	2.14e-05	8.98e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	2.04e-05	8.55e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PIK3CA—malignant glioma	1.95e-05	8.15e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.88e-05	7.88e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.85e-05	7.76e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	1.81e-05	7.59e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AKT1—malignant glioma	1.59e-05	6.66e-05	CbGpPWpGaD
